Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PHF19 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | PCMTD1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | ANKLE1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | KRT75 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | STARD4 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | FDFT1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | DALRD3 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | WDR7 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
mRNA | IAPP | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
mRNA | LAMTOR5 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |